• FirefoxTry Yahoo Finance on Firefox »
  •  Dow down 0.09% Nasdaq up 0.30%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow down 0.09% Nasdaq up 0.30%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolNamePrice52-Wk RangeMkt CapAvg VolEPSP/EYieldPrice/SalesEBITDA
    No such ticker symbol: BFFAF.DETry Symbol Lookup
    Unilever N.V. 42.57 - - 120.85B 16,154 1.93 22.09 3.36 2.06 9.55B
    Essilor International SA 104.90 102.1 125.15 22.39B 426,291 3.62 28.97 - 3.47 1.65B
    No such ticker symbol: DDAIF.DETry Symbol Lookup
    Amgen Inc. 158.51 139.02 176.85 118.62B 2,798,890 9.77 16.22 2.46 5.38 11.34B
    Anheuser-Busch InBev SA/NV 127.05 - - 204.26B 7,641 2.36 53.74 3.63 4.83 16B
    Siemens Aktiengesellschaft 106.45 79.23 109 86.18B 1,755,020 6.40 16.63 - 1.09 9.41B
    Unibail-Rodamco SE 240.85 174 243.8 - 274,146 13.30 - - NaN 0
    Danone 63.47 57.49 70.53 38.81B 1,518,170 2.84 22.39 - 1.78 3.83B
    {"s" : "unlnf,ei.pa,amgn,ahbif,sie.de,ul.pa,bn.pa","k" : "l84,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    [$$] Turnaround at Danone Could Boost Stock 25% at Barrons.com12:01am EDT
    Friday October 21, 2016
    The Moat Stays Strong, Even If the Listing Is Gone Gurufocus05:55pm EDT
    It's Time for Wine to Shine at Super Bowl 51 at TheStreet05:12pm EDT
    Index funds can be inferior to active funds in two crucial ways at MarketWatch04:36pm EDT
    Why Were Altria’s 2Q16 Revenue Lower than Analysts’ Estimates? at Market Realist02:04pm EDT
    Will Amgen (AMGN) Sustain its Earnings Beat Trend in Q3? Zacks10:47am EDT
    Amgen's (AMGN) Xgeva Meets Endpoint in Phase III Study Zacks10:00am EDT
    The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals Zacks09:30am EDT
    Brazilian Woes Hit European Food Companies' Earnings at TheStreet08:29am EDT
    Thursday October 20, 2016
    4:20 pm Amgen announces that a Phase 3 study evaluating XGEVA vs zoledronic acid met the primary endpoint in patients with multiple myeloma Briefing.com04:20pm EDT
    Amgen Announces Positive Top-Line Results From XGEVA® (Denosumab) Phase 3 Trial For Delay Of Bone Complications In Multiple Myeloma Patients PR Newswire04:19pm EDT
    Amgen Partner Kite Not 'A One-Trick Pony'; Pipeline Grows In 2017 at Investor's Business Daily04:03pm EDT
    Asian brewers, KKR-led investors vying for East Europe beer brands-sources Reuters02:50pm EDT
    Unilever's 'Marmitegate' shows strain on consumer industry Reuters11:12am EDT
    7 Drug Stocks to Consider as Biosimilars Pick Up Pace Zacks10:29am EDT
    Biotech Stocks: Do Earnings Even Matter Anymore? at Barrons.com09:58am EDT
    Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains at 24/7 Wall St.09:55am EDT
    What Biogen Is Doing that Put It in Good Favor with Analysts at Market Realist08:05am EDT
    Move Over, Marmite: Consumer Companies Have Much Bigger Problems at Bloomberg06:35am EDT
    Siemens AG breached its 50 day moving average in a Bearish Manner : SIE-DE : October 20, 2016 at Capital Cube03:18am EDT
    [$$] Shine Comes Off Big Consumer-Product Companies at The Wall Street Journal12:49am EDT
    Wednesday October 19, 2016
    [$$] Shine Comes Off Big Consumer-Product Companies at The Wall Street Journal10:06am EDT
    3 Stocks to Supplement Your Social Security Benefits at Motley Fool09:07am EDT
    Big Beer Wants In On Homebrewing at Bloomberg06:00am EDT
    [$$] World’s Biggest Brewer Needs Extra Rounds of Savings at The Wall Street Journal12:12am EDT